Home » Topics » Disease categories and therapies » Dental

Dental
RSS

CollaGenex seeks FDA approval for new dosage form of Periostat

April 5, 2000

Xanthine-based cell adhesion inhibitors particularly useful for periodontitis

March 24, 2000

Periostat receives U.K. marketing approval for treatment of chronic adult periodontitis

March 1, 2000

Periodontix raises funding for further development of HistaWash

Jan. 21, 2000

Atridox periodontal therapy approved in E.U.

Jan. 6, 2000

PAX9 gene mutation results in missing teeth

Jan. 5, 2000

Cathepsin C may be an important mediator in the development of periodontitis

Dec. 16, 1999

Positive phase III trial results for OraPharma's periodontal disease treatment

Dec. 1, 1999

Taiho prepares novel agents for periodontitis

Nov. 11, 1999

Atrix reports postmarketing study results for Atridox periodontitis therapy

Sep. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...